🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to evaluate the pharmacokinetics (PK) and re...
Status
Completed
Location
Acpru /Id# 283349
Start Date
2026-05-12
Trial ID
NCT07587008
Treatments Being Tested
The primary purpose of this study is to assess the long-term safety and tol...
Status
Terminated
Location
Phoenix, Arizona
Start Date
2022-09-01
Trial ID
NCT05443724
Treatments Being Tested
The primary purpose of this study is to assess the effect of renal impairme...
Status
Completed
Location
Tustin, California
Start Date
2023-07-24
Trial ID
NCT05940402
Treatments Being Tested
The primary purpose of this study is to determine the mass balance, routes,...
Status
Completed
Location
Austin, Texas
Start Date
2024-03-04
Trial ID
NCT06301971
Treatments Being Tested
The purpose of this trial is to evaluate plasma concentrations of emraclidi...
Status
Completed
Location
Overland Park, Kansas
Start Date
2023-07-19
Trial ID
NCT05933187
Schizophrenia is a common and severe psychiatric illness characterized by e...
Status
Recruiting
Location
Woodland International Research Group /ID# 275747
Start Date
2025-08-04
Trial ID
NCT07145918
Treatments Being Tested
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Status
Completed
Location
Little Rock, Arkansas
Start Date
2022-06-30
Trial ID
NCT05227690
Treatments Being Tested
This study is to assess how oral emraclidine moves through the body of heal...
Status
Recruiting
Location
Altasciences Clinical Los Angeles /ID# 276854
Start Date
2025-10-08
Trial ID
NCT07219030
Treatments Being Tested
The primary purpose of the study is to evaluate the effect of itraconazole,...
Status
Completed
Location
Overland Park, Kansas
Start Date
2023-08-15
Trial ID
NCT05965219
Treatments Being Tested
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Status
Completed
Location
Bentonville, Arkansas
Start Date
2022-07-05
Trial ID
NCT05227703
Treatments Being Tested